Skip to main content
Search

# Pharmaceutical studies and practices

1 related articles

Subscribe to updates
  1. Across 2,907 FAERS reports on methotrexate in pediatric leukemia, nervous system disorders gave the strongest signal, febrile neutropenia was the most reported PT, and 72.1% of evaluable onsets fell within 30 days

    Drawing 2,907 FAERS reports (Q1 2018–Q1 2025) in which methotrexate was the primary suspect drug for pediatric leukemia, the study applied four disproportionality methods (ROR, PRR, BCPNN, MGPS) with sex and five age strata and fitted time-to-onset with a Weibull distribution, finding that nervous system disorders had the largest SOC-level report count (1,691 cases, ROR 2.87, 95% CI 2.69–3.05), that febrile neutropenia led at the PT level (446 reports) followed by neurotoxicity (238) and mucosal inflammation (170), that confusional state, dehydration, and epistaxis showed greater reporting disproportionality in males, that six PTs were detected in all five age strata, and that 681 of 944 evaluable onset reports (72.

You’re all caught up